Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report
Top Cited Papers
Open Access
- 5 October 2016
- Vol. 66 (1), 6-30
- https://doi.org/10.1136/gutjnl-2016-312288
Abstract
Important progress has been made in the management of Helicobacter pylori infection and in this fifth edition of the Maastricht Consensus Report, key aspects related to the clinical role of H. pylori were re-evaluated in 2015. In the Maastricht V/Florence Consensus Conference, 43 experts from 24 countries examined new data related to H. pylori in five subdivided workshops: (1) Indications/Associations, (2) Diagnosis, (3) Treatment, (4) Prevention/Public Health, (5) H. pylori and the Gastric Microbiota. The results of the individual workshops were presented to a final consensus voting that included all participants. Recommendations are provided on the basis of the best available evidence and relevance to the management of H. pylori infection in the various clinical scenarios.Keywords
This publication has 393 references indexed in Scilit:
- Effects of CYP2C19 Loss-of-Function Variants on the Eradication of H. pylori Infection in Patients Treated with Proton Pump Inhibitor-Based Triple Therapy Regimens: A Meta-Analysis of Randomized Clinical TrialsPLOS ONE, 2013
- Helicobacter Pylori “Test-and-Treat” Strategy for Management of Dyspepsia: A Comprehensive ReviewClinical and Translational Gastroenterology, 2013
- Fifteen-Year Effects of Helicobacter pylori, Garlic, and Vitamin Treatments on Gastric Cancer Incidence and MortalityJNCI Journal of the National Cancer Institute, 2012
- Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)Endoscopy, 2011
- 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trialThe Lancet, 2011
- Lack of Commensal Flora in Helicobacter pylori–Infected INS-GAS Mice Reduces Gastritis and Delays Intraepithelial NeoplasiaGastroenterology, 2011
- Serum Pepsinogens in Gastric Cancer ScreeningDigestive Diseases and Sciences, 2010
- A review of human carcinogens—Part B: biological agentsThe Lancet Oncology, 2009
- Gastric cancer screening using the serum pepsinogen test methodGastric Cancer, 2006
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001